10,470 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Shaker Investments LLC OH

Shaker Investments LLC OH purchased a new stake in Doximity, Inc. (NASDAQ:DOCS) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,470 shares of the company’s stock, valued at approximately $559,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. UMB Bank n.a. raised its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares during the period. Farther Finance Advisors LLC raised its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the period. Morse Asset Management Inc purchased a new stake in Doximity during the third quarter valued at about $46,000. GAMMA Investing LLC boosted its holdings in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the period. Finally, Covestor Ltd increased its position in shares of Doximity by 441.9% in the third quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after acquiring an additional 1,370 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Price Performance

Shares of DOCS stock opened at $83.11 on Tuesday. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The stock has a fifty day moving average price of $56.20 and a 200 day moving average price of $46.30. The stock has a market cap of $15.52 billion, a P/E ratio of 56.56, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39.

Analyst Ratings Changes

Several analysts have issued reports on DOCS shares. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $60.00 to $90.00 in a research note on Friday. Raymond James reissued an “outperform” rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a research note on Friday. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Mizuho increased their price target on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday. Finally, Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 37.40% of the stock is owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.